Výsledky vyhledávání

Akademický článek

Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis

Autor: Ryan J Collinson, Lynne Wilson, Darren Boey, Zi Yun Ng, Bob Mirzai, Hun S Chuah, Rebecca Howman, Carolyn S Grove, Jacques A J Malherbe, Michael F Leahy, Matthew D Linden, Kathryn A Fuller, Wendy N Erber, Belinda B Guo

Publikováno v: Platelets, Vol 35, Iss 1 (2024)

AbstractTranscription factor 3 (TCF3) is a DNA transcription factor that modulates megakaryocyte development. Although abnormal TCF3 expression has been identified in a range of hematological malignancies, to date, it has not been investigated in mye

Externí odkaz: https://doaj.org/article/8a8bf5c785ff42dba6fe62c17e84f290

Zobrazit plný text záznamu

Akademický článek

Neutrophil-dependent Mitochondrial DNA Release Associated With Extracellular Trap Formation in Inflammatory Bowel Disease

Autor: Broc Drury, Cher S. Chuah, Rebecca Hall, Gareth R. Hardisty, Adriano G. Rossi, Gwo-Tzer Ho

Publikováno v: Gastro Hep Advances, Vol 2, Iss 6, Pp 788-798 (2023)

Background and Aims: Inflammatory bowel disease (IBD) is associated with increased circulating damage-associated molecular patterns, in particular, the highly pro-inflammatory mitochondrial DNA (mtDNA). Here, we study the importance of blood neutroph

Externí odkaz: https://doaj.org/article/54c3abbc21154a52a47b0378933a9b8c

Zobrazit plný text záznamu

Akademický článek

REVIEW OF HYDROGEN FUEL FOR INTERNAL COMBUSTION ENGINESREVIEW OF HYDROGEN FUEL FOR INTERNAL COMBUSTION ENGINES

Autor: M. Faizal, L. S. Chuah, C. Lee, A. Hameed, J. Lee, M. Shankar

Publikováno v: Journal of Mechanical Engineering Research and Developments, Vol 42, Iss 3, Pp 35-46 (2019)

In the world that we live in today, non-renewable sources of energy are being depleted at an exponential rate. Thus, alternative sources of fuel have become more important to prevent the occurrence of an energy crisis. Seeing that hydrogen is not a s

Externí odkaz: https://doaj.org/article/61334c8f008641e2af7d39efdb8e4b80

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P127 Inflammatory Bowel Disease-associated colorectal cancers: retrospective cohort study from a tertiary centre surveillance programme over 10 years

Autor: R Porter, S L Gillespie, M Song, G Ball, A Crawford, A Churchhouse, M Gardner, N Plevris, C S Chuah, W Brindle, E Watson, P Jenkinson, J Fulforth, M Kedziora, B Dickson, A Megan, G R Jones, S Din

Publikováno v: Journal of Crohn's and Colitis. 17:i293-i293

Background Patients with IBD have increased risk for developing colorectal cancer (CRC), with poorer survival, compared to those without IBD. Despite surveillance colonoscopy, IBD post-colonoscopy CRC (PCCRC) rates are unacceptably high at 28-45%. We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d8e87953e51005c48f4989d82e732a6d
https://doi.org/10.1093/ecco-jcc/jjac190.0257

Zobrazit plný text záznamu

P328 Holistic well-being as Patient-reported outcomes (PROs) in translational IBD research: Prospective capture of CUCQ32 as study endpoints for mechanistic biomarker MUSIC/GIDAMPs study

Autor: R Hall, C S Chuah, E Brownson, B Poulose, O Athena, C Mowat, J Macdonald, J P Seenan, G T Ho

Publikováno v: Journal of Crohn's and Colitis. 17:i467-i467

Background There is increasing recognition of ‘holistic’ wellbeing as a key target in the management of IBD. Patient-reported outcomes (PROs) capture the impact of IBD on social, emotional and general wellbeing. Recently, regulatory bodies such a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bc954bfe3e32c3ffed80d7548dcbbf0c
https://doi.org/10.1093/ecco-jcc/jjac190.0458

Zobrazit plný text záznamu

Association of trough vedolizumab levels with clinical, biological and endoscopic outcomes during maintenance therapy in inflammatory bowel disease

Autor: Mathew Lyons, Ian D. Arnott, Nikolas Plevris, Philip Jenkinson, Cher S Chuah, Charlie W. Lees, Rebecca J Pattenden, Lynne M Merchant, Gareth R. Jones

Publikováno v: Frontline Gastroenterol

ObjectiveTo establish the relationship between trough vedolizumab levels and outcomes during maintenance therapy.DesignCross-sectional service evaluation was performed on patients with inflammatory bowel disease (IBD) receiving maintenance vedolizuma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3529ba5eea24a378602b5a527236d5bb
https://doi.org/10.1136/flgastro-2019-101197

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání